Generic Name:
Bevacizumab
Project Status:
Complete
Therapeutic Area:
Cervical Cancer
Manufacturer:
Hoffmann-La Roche Limited
Brand Name:
Avastin
Project Line:
Reimbursement Review
Project Number:
PC0045-000
Details
Strength:
25mg/mL
Tumour Type:
Gynecology
Indications:
Cervical Cancer
Funding Request:
In combination with chemotherapy for the treatment of patients with persistent, recurrent, or metastatic carcinoma of the cervix
Review Status:
Complete
Pre Noc Submission:
Yes
Sponsor:
Hoffmann-La Roche Limited
Submission Date:
Submission Deemed Complete:
Prioritization Requested:
Requested and Not Granted
Stakeholder Input Deadline ‡:
Check-point meeting:
pERC Meeting:
Initial Recommendation Issued:
Feedback Deadline ‡:
Notification to Implement Issued:
Recommendation Type:
Reimburse with clinical criteria and/or conditions
pERC Meeting:
Final Recommendation Issued: